17 responses to “New targets for Diabetes (A1C): Why we are aiming at ‘only’ 7 percent”

  1. Thank you

  2. Already do the same

  3. I am already aware of the evidence and changing guidelines with respect to AIC goals. I mostly agree with new approach,with some reservations for some cases. I have already changed my practice accordingy. I voted that I did not agree with the approach because there was no option available to say that I agree and have already made the appropriate change to my practice.

  4. clear article in all the confusion

  5. Seems wise to me. I have been on to this for some time.

  6. I agree

  7. Totally in agreement. A sensible, practical approach. Seemed like overkill in the past to push aggressive treatment on the elderly with associated risks of hypoglycemia.

  8. Reasonable and achievable in most people if they’re compliant.

  9. I have not been successful in trying to get Hgb A1C lower than 7 in Type 2 diabetics anyway, so this is good news.

  10. thank you, have incorporated this into my practice

  11. Been doing same but allowing for more latitide in elderly with co-morbidities.

  12. No commnet, I already do it

  13. Thank you. These are helpful guidlines.

  14. the imformations have comfimed what I have done right

  15. I agree. Do not add a significant mortality risk if there is no mortality benefit … firstly do no harm …

  16. Yes, I agree with with the above comments except the ACCORD trial is a very complex one. If we take a look at those who did not achieve the target A1C in the intensive arm were the one landing with increased mortality. Those in the intensive arm achieving their targets had positive CVD outcomes. Similarly in VADT those with a low CAC score (<100) had CVD benefits. There fore t is not possible to draw a razor sharp line when it comes to clinical practice. We might come across an individual around 65 years of age newly diagnosed with T2DM without micro- or macro-vascular complications. What do we do? Just because the age falls in the CCORD,ADVANCE, VADT range is it justified refraining from intensive strategy. The individuals with high baseline A1C, high CVD risk/established CVD, advanced microvascular complications & long duration of diabetes can be put in the relaxed bracket.

  17. I DO AGREE BUT TREATING AND KEEPING HBAIC BELOW 6 THERE IS DEFINITE BENEFITS IN REDUCING THE COMPLICATIONS OF DIABETES

Leave a Reply